Header cover image

Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

UPDATED Nov 27, 2022

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

55 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
BNTXBioNTechUS$154.85-6.9%-55.5%US$37.6bUS$209.31PE3.5xE-40.8%n/a
3320China Resources Pharmaceutical GroupHK$6.22-5.3%85.1%HK$39.1bHK$6.68PE9xE-2.8%2.4%
2422Sichuan Kelun PharmaceuticalCN¥23.38-4.4%24.3%CN¥32.8bCN¥23.03PE19.7xE5.9%1.8%
600566Hubei Jumpcan PharmaceuticalCN¥31.97-6.1%76.2%CN¥29.5bn/aPE14.5xE10.2%2.1%
ABCLAbCellera BiologicsUS$13.52-4.5%-3.4%US$3.9bUS$29.33PE15.6xE-59.6%n/a
APNAspen Pharmacare HoldingsR145.51-2.6%-35.1%R64.5bR184.67PE10xE7.4%2.2%
600380Joincare Pharmaceutical Group IndustryLtdCN¥12.10-6.1%0.6%CN¥22.6bCN¥16.00PE15.6xE19.5%1.2%
600867Tonghua Dongbao PharmaceuticalCN¥9.20-1.3%-17.5%CN¥18.2bCN¥10.80PE11.1xE-7.2%5.4%
2737Sunflower Pharmaceutical GroupLtdCN¥27.89-9.3%90.2%CN¥16.2bn/aPE19.9xn/a2.5%
605507Guobang PharmaCN¥28.94-3.7%4.0%CN¥16.2bn/aPE17.9xE24.2%0%
SQURPHARMASquare Pharmaceuticals৳212.601.3%-2.1%৳188.5b৳332.00PE10.2xE11.6%4.7%
4540TsumuraJP¥3,060.000.5%-5.4%JP¥233.8bJP¥3,500.00PE11.3xE10.6%2.1%
PHMPharma Mar€65.841.3%13.7%€1.2b€76.86PE14.2xE15.4%1.0%
A006280Green Cross₩131,500.001.9%-39.7%₩1.5t₩191,222.22PE13.8xE3.6%1.5%
MEGAMega Lifesciences฿45.75-2.1%-14.9%฿39.9b฿55.44PE17.1xE6.1%3.5%
601089Beijing Winsunny PharmaceuticalLTDCN¥16.18-5.3%n/aCN¥7.8bn/aPE20xn/a0%
2395Shin Nippon Biomedical LaboratoriesJP¥2,721.004.5%68.5%JP¥113.3bJP¥4,200.00PE14.1xE4.9%1.5%
688767Hangzhou Biotest BiotechLtdCN¥50.87-10.3%-29.3%CN¥5.4bn/aPE5.4xn/a5.9%
A185750Chong Kun Dang Pharmaceutical₩84,100.00-2.2%-17.1%₩977.4b₩115,800.00PE13.8xE0.8%1.1%
A003850Boryung₩10,500.00-0.9%-27.1%₩691.8b₩15,500.00PE12.8xE2.4%1.0%
A086450DongKook Pharmaceutical₩15,450.00-4.3%-21.2%₩679.1b₩23,666.67PE11.5xE21.5%1.2%
AIPAdcock Ingram HoldingsR49.90-0.1%10.8%R8.1bR52.50PE10.1xE-3.7%4.4%
AVIRAtea PharmaceuticalsUS$4.690.4%-42.4%US$390.6mUS$10.50PE11xE-17.7%n/a
3705YungShin Global HoldingNT$40.05-0.5%-8.0%NT$10.7bn/aPE11.1xn/a4.2%
Page 1 of 3